Yuliia Huba1, Lyudmyla Konopkina1
and Nataliia Sanina2
Medicine 1, SE Dnipropetrovsk Medical Academy of the
Ministry of Health of Ukraine, Dnipropetrovsk, Ukraine, 2SI
Ukrainian State Research Institute of Medical and Social
Problems of Disability MoH of Ukraine, Dnipropetrovsk,
It is known that anxiety is
one of the
comorbidities in pts with COPD and it has a negative impact on the pts'
to study the severity of anxiety in COPD pts and it's correlation with
severity of symtoms of COPD.
methods: we studied two groups of pts: main group
110 COPD pts GOLD 1-4 (age 63,50,9
yrs, males 93 (84,63,5%)) and control group
15 pts without any clinically relevant diseases ((age
60,22,3 yrs (p=0,184), males 13
(86,88,8%) (p=0,817)). Measurements included clinical
status, spirometry, mMRC and CAT scales, the State-trait anxiety
inventory (STAI) for detection of anxiety.
it was detected that level of state anxiety in main group and in
control group was not significantly different (40,20,9 and
37,72,5 resp. (p=0,328)). The level of trait anxiety in the
main group and in control group was not significantly different
(44,80,8 and 41,52,2 resp. (p=0,157)) also.
At the same time, it was revealed that in the main group the level of
state anxiety correlated with the level of dyspnea due to mMRC
(p=0,005), level of COPD symptoms due to CAT (p<0,001), but did
not correlate with the level of FEV1 (p=0,427). The level of trait
anxiety in the same group correlated with the level of dyspnea due to
mMRC (p=0,019), level of COPD symptoms due to CAT (p<0,001), but
did not correlate with the level of FEV1 (p=0,790).
the severity of state and trait anxiety is not different in COPD pts
and in healthy pts of the same age. The severity of state and trait
anxiety is more related with the severity of symptoms of COPD than with
the degree of airflow limitation.
Image : https://www.greenwayhealth.com/wp-content/...